Gerben Zondag Email and Phone Number
Gerben Zondag work email
- Valid
- Valid
Gerben Zondag personal email
Specialties: Life Sciences, Synthetic DNA, R&D, Management, Business Development, Technology Transfer and Matchmaking.
Synvolux Therapeutics B.V.
View-
CeoSynvolux Therapeutics B.V. Sep 2015 - PresentLeiden, Zh, NlSynvolux is a Dutch, privately owned company that develops breakthrough methods for synthetic DNA production, and markets highly efficient, non-viral transfection reagents for intracellular delivery of DNA, RNA(i), peptides, and proteins. Its RMADA™ platform allows cell-free, rapid, scalable and error-free production of DNA. SAINT™ technology is based on a panel of proprietary, entirely synthetic lipid structures that have been demonstrated to be safe, non-toxic, and broadly applicable for both research and clinical applications. Synvolux has a broad, international customer base, active programs in the field of DNA and mRNA vaccines, and is open to discuss partnerships.
-
Immunetune Founder & CooImmunetune Bv Aug 2021 - Present
-
Vice President Technology AffairsVitalnext B.V. 2013 - PresentVitalNext brings together the worlds of Life Sciences and consumer products. Healthy Ageing is an important topic in most societies throughout the world. The increasing life expectancy of most people creates a demand for products that keep us in good health for prolonged periods of time. Besides the classical approach of ‘curing disease when it arises’, the importance of lifestyle and nutrition in prevention of disease is now widely recognized, but still grossly underestimated.VitalNext develops proprietary nutritional products with evidence-based health benefits through extensive research and clinical testing within our own network and through collaborations with our research partners. These products are commercialized via distribution agreements with specialized business partners.
-
OwnerSequrex Life Sciences Consulting Aug 2010 - PresentOegstgeest, NlSequrex offers professional and independent support and consultancy services in the field of Life Sciences. With over 20 years of experience in both academic and corporate settings and a large network of experts, Sequrex supports both start-ups and established companies, research institutions, NGOs, and government bodies in various aspects of Life Sciences. Please visit www.sequrex.com for more information. -
CeoImmunetune Jan 2017 - Sep 2021Immunetune, a pioneering biotech company based in Leiden (the Netherlands), is developing personalized DNA-based vaccines to treat highly mutated cancer types. In close collaboration with the Leiden University Medical Center, we develop vaccines that train the immune system to selectively identify and eliminate tumor cells based on tumor-specific DNA mutations (neoantigens), thus yielding a type of precision medicine with an excellent safety profile.
-
Business Development & Commercialisation AdvisorLeiden University Aug 2011 - Sep 2014Leiden, South Holland, NlScouting, IP protection, and licensing of innovative research emerging from Leiden University and its Medical Center -
Business DeveloperLeiden University Medical Center Aug 2011 - Sep 2014Leiden, Zuid-Holland, NlTechnology scouting, patenting, commercialization, licensing, research collaborations, spin-off company formation -
Director And Co-FounderSwan Diagnostics Aug 2010 - Jan 2013
-
Vp Technology AffairsDnage Bv Jan 2009 - Jul 2011
-
Director Of ResearchDnage Apr 2006 - Dec 2008Ageing research
-
Scientific DirectorBaseclear Dec 2001 - Mar 2006
-
ScientistPharming Jan 2000 - Nov 2001Leiden, Nl -
Postdoctoral ResearcherThe Netherlands Cancer Institute Jan 1998 - Dec 1999Amsterdam, North Holland, Nl
Gerben Zondag Skills
Gerben Zondag Education Details
-
The Netherlands Cancer InstituteCellular & Molecular Biology -
Leiden UniversityBiology
-
Delft University Of TechnologyChemical Technology
Frequently Asked Questions about Gerben Zondag
What company does Gerben Zondag work for?
Gerben Zondag works for Synvolux Therapeutics B.v.
What is Gerben Zondag's role at the current company?
Gerben Zondag's current role is Experienced Life Science executive | Founder of Immunetune | CEO of Synvolux and Sequrex.
What is Gerben Zondag's email address?
Gerben Zondag's email address is ge****@****ndag.cc
What schools did Gerben Zondag attend?
Gerben Zondag attended The Netherlands Cancer Institute, Leiden University, Delft University Of Technology.
What are some of Gerben Zondag's interests?
Gerben Zondag has interest in Life Science, Biotechnology, Business Development, Venture Capital, Ageing Research, New Technologies, Science And Technology, Startups, Challenging Jobs, Health.
What skills is Gerben Zondag known for?
Gerben Zondag has skills like Biotechnology, Lifesciences, Life Sciences, Molecular Biology, Science, Technology Transfer, Pharmaceutical Industry, Intellectual Property, Start Ups, Patents, Licensing, Immunology.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial